Coronavirus tests U.S. medical system’s unhealthy reliance on China for drugs, supplies.
The basic building blocks of U.S. health care are now under the control of the Chinese Communist Party.
It’s not just the “building blocks of U.S. health care”, it’s all the stuff imported from China and how much of that stuff we depend on that’s not being manufactured because of so many people being in quarantine.
Chinese President Xi Jinping recently warned of the “grave” situation posed by the “accelerating spread” of the coronavirus in China. Xi’s frank warnings were unusual for the seniormost official of the Chinese Communist Party and reveal the depth of the concern at the highest levels of the country’s leadership.
Already, nearly 500 people have died and tens of thousands more have been diagnosed with the novel coronavirus. It has been found in Taiwan, South Korea, Japan, Europe and the United States. Tens of millions have been put under travel restrictions and even quarantine by the Chinese government.
While many are rightfully concerned about stopping the virus, few are focused on the fact that the more it spreads, the more the U.S. ability to treat any Americans who are stricken is vulnerable to the tender mercies of the Chinese Communist Party because of a strategic shift in health care that occurred without debate or decision in Washington.
Everything from antibiotics to chemotherapy drugs, from antidepressants to Alzheimer’s medications to treatments for HIV/AIDS, are frequently produced by Chinese manufacturers. What’s more, the most effective breathing masks and the bulk of other personal protective equipment — key to containing the spread of coronavirus and protecting health care workers — and even the basic syringe are largely made in China. The basic building blocks of U.S. health care are now under Xi’s control.
As Rosemary Gibson, author and health care expert noted, the United States does not produce its own penicillin anymore — the last U.S. based penicillin production facility closed in 2004. Of course, antibiotics may not do any good against the coronavirus, but they may be needed to deal with a related sickness, just as flu often leads to respiratory infections.
This makes the U.S. acutely vulnerable for several reasons. First, China has a record of faulty products and poor oversight that have resulted in recalls, production delays and other problems Americans certainly don’t want to encounter when trying to obtain lifesaving drugs. As Secretary of Commerce Wilbur Ross stated recently, it is time for the U.S. to “consider the ramifications of doing business with a country that has a long history of covering up real risks to its own people and the rest of the world.”